Spragens Jeffrey G 4
4 · SAB Biotherapeutics, Inc. · Filed Dec 9, 2022
Insider Transaction Report
Form 4
Spragens Jeffrey G
Director
Transactions
- Award
Warrant (Common Stock)
2022-12-07+82,987→ 82,987 totalExercise: $1.08From: 2023-06-07Exp: 2027-12-07→ Common Stock (82,987 underlying) - Award
Common Stock
2022-12-07$1.21/sh+82,987$99,999→ 394,989 total
Footnotes (1)
- [F1]On December 6, 2022, the Registrant entered into a securities purchase agreement with Mr. Jeffrey Spragens in connection with a private placement conducted by the Registrant, pursuant to which Mr. Spragens purchased (i) an aggregate of 82,987 shares (the "Shares") of the Registrant's common stock, par value $0.0001 per share and (ii) warrants to purchase up to an aggregate of 82,987 shares of common stock at an exercise price of $1.08, at a combined purchase price of $1.205 per share and accompanying warrant. The warrants are exercisable six months from the date of issuance and expire five years from the date of issuance.